Prognostic value of mismatch repair deficiency in patients receiving first-line fluoropyrimidine plus platinum for metastatic, recurrent, or unresectable gastric cancer
ConclusionsEfficacy of first-line FP was not different by MMR status in mGC patients.
Source: Gastric Cancer - Category: Gastroenterology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Gastric (Stomach) Cancer | Gastroenterology | Gastroschisis Repair | HER2 | Statistics